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I.

ABSTRACT
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized
by the progressive death of dopaminergic neurons present in the substantia nigra. The
clinical presentation of PD includes tremors, slowed movement (bradykinesia),
muscle and limb rigidity, and difficulty with walking and balancing. While many
environmental factors can affect the onset and progression of the disease, genetic
mutations have a large influence. Of the identified PD-linked genetic mutations,
mutations in the leucine-rich repeat kinase 2 (LRRK2) are one of the most common
genetic causes of PD. Located in endosomes, LRRK2 has been shown to play a role
in the sorting and endocytosis of synaptic vesicles, a process that is largely mediated
by the retromer complex. Mutations in Vps35, a core component of the retromer
cargo-recognition complex, have also been identified as a significant cause of lateonset autosomal dominant familial PD. While the exact molecular mechanisms by
which LRRK2 and Vps35 mutations induce PD remain largely unknown, their
influence on several cellular processes, including vesicular trafficking and
breakdown, and endosomal sorting and recycling, strongly implicate the retromer and
autophagy in PD pathology. Recent findings that transgenic expression of Vps35 is
able to rescue the PD-related phenotypes caused by LRRK2 mutant forms provide
further insight into the interplay of these genes in the context of PD and point to these
-genes as potential therapeutic targets. This review outlines the current studies
involving these genetic mutations and their interactions with various cellular
processes and pathways so as to gain a better understanding of the molecular
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mechanisms underlying PD pathology for the ultimate purpose of developing safe and
effective treatments for PD.
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II.

BACKGROUND

a) The growing need for effective treatments for PD
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders,
second only to Alzheimer’s disease. Affecting almost 700,000 individuals over the
age of 45 in the United States in 2010, PD is expected to continue to increase in
prevalence to affect more than one million people in the U.S. by 2030 (Marras et al.,
2018). With an average onset around age 55, PD is a progressive disease and
demonstrates markedly worse symptoms at its later stages. Due to the loss of
dopaminergic neurons in the substantia nigra and the subsequent decrease in
dopamine signaling occurring in the basal ganglia, PD is most commonly recognized
through an affected individual’s loss of motor function. This deterioration of motor
function clinically presents as bradykinesia, rigidity in gait and limb movement,
postural instability, as well as tremors (Brazier, 2018). Further symptoms can include
hyposmia, constipation, mood disorders, sleep disorders, cognitive defects, and
dementia which only serve to lower the quality of life for affected individuals
(Ascherio & Swarzschild, 2016, Rahman & Morrison, 2019). Because the symptoms
and complications of PD are severe and its burden on society is expected to grow as
the average lifespan has increased, a larger value has been placed on research
focusing on understanding the cellular and molecular processes underlying PD
neurodegeneration so as to identify biological targets and develop therapeutic
treatments.
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b) Drosophila melanogaster as an important animal model for studying PD

Due to limitations of human genetic studies, animal models are important for
studying the function of genes and proteins involved in cellular pathways implicated
in neurodegenerative disorders. While many model organisms, such as yeast, rats, C.
elegans, and zebrafish, can provide great insight into the molecular mechanisms
underlying PD, many fall short in meeting all of the necessary criteria to carry out a
robust and effective study of human PD. The criteria for transgenic models include
observable behavioral and physiological defects, a clear pattern of inheritance, a welldefined and easily-analyzed nervous system, and the conservation of cellular
pathways (Hirth, 2010). Drosophila melanogaster, also known as the common fruit
fly, are an especially powerful animal model for studying Parkinson’s disease as they
are not only easily available, rapidly reproducing, and have short life-spans but also
stand alone in their fulfillment of these criteria for studying human
neurodegeneration. Transgenic Drosophila models with PD-linked genetic
mutations, unlike rat models which fail to manifest the cardinal pathological features
of PD seen in humans, consistently reproduce dopaminergic neuron death and
demonstrate locomotor defects in complicated behaviors, such as climbing and
walking (Linhart et al., 2014, Xiong & Yu, 2018). Further, many of the fundamental
cellular processes, genes, and signaling pathways are conserved in both Drosophila
and humans, as many of the genes associated with familial PD have at least one fly
homolog (Muñoz-Soriano & Paricio, 2011). This stands in contrast to other proposed
model organisms, such as C. elegans, which have far fewer gene homologs in
mammals and lack many biologically and physiologically relevant systems seen in
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both flies and humans. Drosophila also possess a wide array of genetic tools
including transgenic methods for gene manipulation, systems for controlled ectopic
expression of certain genes, and balancer chromosomes. As the Drosophila genome
is encoded on only four chromosome pairs, balancer chromosomes allow not only
allow for inclusion of visible molecular markers but also for the suppression of
recombination to effectively follow mutations across many generations (Cauchi &
van den Huevel, 2006). One of the most interesting features of the fruit fly, however,
is its compound eye. Composed of nearly 800 ommatidia, each of which contain 8
photoreceptor neurons, the Drosophila eye is extremely useful for studying
neurodegenerative phenotypes as its organized and symmetrical layout of
photoreceptors allows for easy quantification of neurodegeneration. In analyzing the
eye in flies expressing a PD-linked mutation, the level of pigmentation loss, bristle
organization, and appearance of black lesions can provide information about the
neurodegenerative phenotype (Mishra & Knust, 2013, Marcogliese et al., 2017). The
eye is also tolerant to genetic disruption of biological processes yet vital to fly
survival (Sang & Jackson, 2005; Cauchi & van den Huevel, 2006).
In making a fly model to study PD, the most common approaches are to
ectopically express a human disease gene (either in wild-type of mutant form) or to
generate a loss-of-function mutation in the Drosophila homolog. Expressing a human
gene through the use of a UAS-Gal4 system can yield insight on its function
properties and its interactions with other Drosophila genes and proteins. Conversely,
inducing a loss-of-function mutation through UAS-Gal4 mediated RNA interference
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can provide a better understanding of the role of the fly homolog, thereby allowing
for predictions about pathogenic pathways underlying the disease.
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c) Autophagy dysfunction is a hallmark of neurodegenerative disorders

Autophagy is an essential cellular process by which cytosolic components in the cell,
especially protein aggregates or damaged organelles, are degraded and recycled by
lysosomes. Initially discovered in yeast as a physiological response to starvation,
autophagy is induced in response to conditions of cellular stress, including nutrient
deprivation, oxidative stress, and the presence of abnormal cellular components. New
evidence further suggests a neuroprotective role for autophagy through its prevention
of the accumulation of harmful products in the brain (Lynch-Day et al., 2012,
Papinski et al., 2014). As it is important for the maintenance of homeostatic
conditions and is involved in a wide range of physiological functions, dysregulation
of autophagy is strongly implicated in the pathophysiology of neurodegenerative
disorders. This is supported by evidence demonstrating that autophagy dysfunction
leads to the accumulation of abnormal and potentially toxic proteins, a hallmark
condition commonly observed in the brains of PD patients (Mizushima & Komatsu,
2011).
There are three forms of autophagy: macroautophagy, microautophagy, and
chaperone-mediated autophagy. The most common type of autophagy in the cell is
macroautophagy, which will hereafter be solely referred to as autophagy. The
process of autophagy, as outlined in Figure 1, begins when an isolation membrane, or
phagophore, sequesters a portion of the cytoplasm–which commonly includes
organelles–to form a double-membrane autophagosome at a site close to the vacuolar
membrane, known as the preautophagosomal structure (PAS) (Mizushima, 2007).
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This structure then fuses with a lysosome to become an autophagolysosome and
breaks down the materials it contains.

Figure 1. A brief outline of the basic steps of macroautophagy, wherein a
phagophore engulfs its cargo to become an autophagosome–whose maturation is
mediated by multiple Atg proteins as well as vacuolar protein sorting (VPS)
complexes in the PAS–until it fuses with a lysosome to form an autophagolysosome,
which thereafter carries out cargo degradation (Figure courtesy of Mizushima, 2007)

The process of autophagy is dependent on specialized autophagy-related (Atg)
genes and the proteins they encode. While each of these proteins are necessary for
different aspects of autophagy, Atg9, the sole multipass transmembrane membrane, is
especially important, as it travels between the site of phagophore nucleation and
autophagosome formation and is thought to transport the membrane needed for
autophagosome formation (Lynch-Day et al., 2012). The trafficking of Atg9 through
the process of endosomal recycling is therefore essential for autophagy. It further
colocalizes with the largest subunit, Vps35, of the retromer complex (Zavodszky et
al., 2014). The retromer, a protein complex, is crucial for the endosomal sorting
machinery that transports and recycles transmembrane receptors from endosomes to
the trans-Golgi network (TGN). Atg9 also colocalizes with the WASH complex, an
actin-regulatory network of proteins that, along with the retromer at the membrane,
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plays a role in endosomal trafficking and recycling (Zavodszky et al., 2014). These
association between Atg9 and Vps35 of the retromer complex and the WASH
complex demonstrates a functional relationship between the retromer and autophagy–
a connection important for understanding PD pathology.
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d) The genetic association between the retromer and PD

The retromer was first implicated in the pathology of PD with the discovery of a point
mutation to the Vps35 subunit of the retromer. This specific mutation of an aspartate
to asparagine at residue 620 (D620N) was identified through exome sequencing in
individuals with PD and remains one of the only confirmed pathogenic Vps35
mutations (Vilariño-Güell et al., 2011, Williams et al., 2017). While the exact
mechanism by which this Vps35 (D620N) mutation induces neurodegeneration
remains unknown, the identification of this mutation in a number of individuals with
PD has demonstrated the retromer’s pathogenic role in PD development.
The retromer complex, first discovered in yeast, is composed of a cargorecognition trimer, made up of the proteins Vps35, Vps26, and Vps29, and a
membrane-associated dimer of sorting nexin (SNX) proteins Snx1, Snx2, Snx5, and
Snx6, in various combinations (Fig 2) (Swarbrick et al., 2011). Responsible for
recycling and trafficking cargo molecules and transmembrane proteins from
endosomes to the trans-Golgi network (TGN), the retromer complex is an integral
part of the endosomal protein sorting system (Maruzs et al., 2015). Because it
mediates the recycling of receptors that are involved in the transportation of
hydrolytic enzymes to lysosomes, the retromer also plays a part in the early stages of
autophagy and endocytosis (Maruzs et al., 2015).
The cargo-recognition complex (CRC) trimer (also referred to as the cargoselective complex, or CSC), composed of Vps26, Vps29, and Vps35, is responsible
for recognizing and binding to trafficking receptors (Williams et al., 2017). Vps35 is
the largest protein in the CRC trimer and functions as the scaffold for which Vps29
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can bind to its C-terminal end and Vps26 can bind to its N-terminal end (Swarbrick et
al., 2011, Williams et al., 2017).
The SNX-BAR dimer, made up of sorting nexin proteins Snx1 or Snx2 and
Snx5 or Snx6, induces membrane remodulation and facilitates the stabilization of
endosomal tubules. The sorting nexin proteins associated with the retromer complex
are characterized by a phox homology (PX) domain, with a high affinity for binding
phosphatidylinositol phosphate membrane lipids, and a Bin/Amphiphysin/Rvs (BAR)
domain, which functions in recruitment to the membrane and stabilization of
tubulation (Collins, 2008).

Figure 2. A schematic representation of the retromer complex. Made up of
Vps26, Vps29, and Vps35, the cargo-recognition complex (CRC)–or cargo-selective
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trimer, as its termed here–interacts with the Snx-BAR dimer largely through the
cooperation of Vps35 and Vps29. Vps35 plays an important role in recruitment of
the CRC to the endosomal membrane while PI3P–or Ptdln3-P, in this figure–
functions as the binding site for the PX domain of the Snx-BAR dimer, allowing for
separate recruitment to the membrane. Together making up the retromer complex,
the CRC and the Snx-BAR dimer allow for endosome-to-Golgi retrieval of cargo
molecules and other proteins (Figure courtesy of Harbour & Seaman, 2011).

To transport cargo, the CRC must first be recruited to the endosomal
membrane. It has been shown that Rab7a and Snx3 are required for recruitment of
the cargo-recognition complex, as the loss of either causes a displacement of the CRC
(Vardarajan et al., 2012). It has further been shown that Snx3 interacts specifically
with the Vps35 subunit of the CRC, suggesting that Vps35 is integral for correct
recruitment of the CRC to the endosomal membrane and, therefore, for proper cargo
trafficking (Seaman, 2012). The Snx-BAR dimer is separately recruited to the
membrane of early endosomes and is able to interact with the CRC through its PX
domain, which binds to phosphatidylinositol 3-phosphate (PI3P) present on the
membrane (Williams et al., 2017). Produced by the phosphoinositide 3-kinase
(PI3K), Vps34, PI3P is able to recruit Rab7a and Snx proteins. As the connection
between the CRC and Snx-BAR dimer is not very strong, Rab7a is important in
strengthening their association with the endosomal membrane.
Another important action of the retromer is its interaction with the WiskottAldrich Syndrome Protein and SCAR Homolog (WASH) complex. Composed of
Wash1, Fam21, CCDC53, KIAA1033/SWIP, and strumpellin, the WASH complex
plays a role in endosomal sorting, as it is a nucleation-promoting factor and regulates
the generation of actin filaments and networks (Seaman et al., 2013, Wang et al.,
2014). Shown in Figure 3, the interaction of Vps35 of the retromer complex with the
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unstructured tail domain of Fam21 of the WASH complex allows for recruitment of
the WASH complex to the endosomal membrane so as to function in endosome-tocell surface retrieval and trafficking of cellular cargo and receptors. At the
membrane, the WASH complex promotes the formation of actin domains which act
to restrict retromer cargo proteins and thereby concentrate cargo, such as the cationindependent mannose 6-phosphate receptor (CIMPR), in specific areas for endosometo-TGN retrieval (Seaman, 2012, Williams et al., 2017). The WASH complex can
further interact with Snx27 and the retromer to regulate the endosome-to-plasma
membrane transport of ß2-adrenergic receptor (ß2AR), which mediates smooth
muscle relaxation, and the glucose transport 1 (GLUT1), which facilities glucose
transport to the brain (Williams et al., 2017).
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Figure 3. A schematic representation of the interaction of the retromer complex
and WASH complex and their role in endosomal sorting. The WASH complex,
responsible for regulating actin filament branching, associates with Vps35 of the
cargo-recognition complex through the ‘tail’ of Fam21. The CRC, WASH complex,
and Snx27 facilitate the endosome-to-cell surface retrieval of ß2-adranergic receptor.
The WASH complex also plays a role in the endosome-to-Golgi retrieval of CIMPR,
a retromer cargo protein (Figure courtesy of Seaman, 2012).
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e) Leucine-rich repeat kinase 2 (LRRK2) mutations induce PD

Mutations to the leucine-rich repeat kinase 2 (LRRK2) gene are the most common
cause of late-onset autosomal dominant PD. Identified LRRK2 mutations, including
N1437H, R1441C/G/H, Y1699C, G2019S, and I2020T, are responsible for more
cases of familial PD than any other implicated genes (Williams et al., 2017). The
mechanisms by which these mutations induce PD pathology, however, remains
unclear.
LRRK2 is a large (2527 amino acid) multi-domain protein characterized by its
carboxy-terminal of Ras of complex (COR) sequence which links its Ras of complex
(Roc) G-domain and kinase domains. Due to its distinct domains, LRRK2 is able to
catalyze phosphorylation through its kinase domain and function in GTP-GDP
hydrolysis through its ROC-GTPase domain (Li et al., 2014). While many of its roles
remain unknown, LRRK2 is expressed in most cells, pointing to its involvement in a
variety of basic cellular functions. Further studies have implicated LRRK2 in
endolysosomal trafficking, the transport and sorting of proteins, and synaptic vesicle
trafficking (Linhart et al., 2014). This was supported by evidence that LRRK2
mutations cause defects in both lysosomal protein degradation and macroautophagy
(MacLeod et al., 2013). Alegre-Abarrategui et al. procured direct evidence for a
functional relationship of LRRK2 and autophagy by demonstrating that the LRRK2
mutation caused accumulation of autophagic vesicles, a hallmark pathological feature
of neurodegenerative disorders, especially PD (2009). The knowledge that both
Vps35 and LRRK2 mutations recapitulate key pathological features of
neurodegenerative disorders, including the impairment of endosomal cargo
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trafficking and sorting as well as the disruption of autophagy, lends itself to the idea
that Vps35 and LRRK2 may operate in a common pathway and interact to induce PD
pathology.
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III.

METHODS

Drosophila melanogaster models are typically used to study the effects of the Vps35
(D620N) and LRRK2 (I2020T) mutations and their interactions in causing PD
symptoms. While many genetic screens can allow for identification of influential
genetic mutations as well as components in pathways of interest, phenotypic analyses
are just as important. A climbing assay and eye phenotype analysis can provide
information about the presence of key pathological features of PD.

a) Climbing Assay

A reliable and cost-effective system, the climbing assay is used to analyze the
locomotor defects of the PD-linked mutant flies. This climbing assay is effective as it
capitalizes on negative geotaxis, or the innate escape response of Drosophila to
ascend the walls of a cylinder after being forced to the bottom.
The day before the climbing assay, 10 female flies are collected using CO2
anesthetization methods under a microscope and placed in a 3.8 cm x 10 cm
collection vial containing a cornmeal food mixture. Left in an incubator kept at 29ºC
overnight, the flies were then transferred to an empty collection vial that had a
horizontal line drawn on it 8 cm from the bottom and which was closed off with a
cotton ball to prevent flies from escaping. The vial was then tapped three times on
the table surface so as to displace the flies to the bottom of the vial. The number of
flies that crossed the horizontal line after 10 seconds and then 20 seconds was
recorded and filmed with a camera placed about 10 inches away from the vial. This
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climbing assay was performed on wild-type flies without any mutations (DDC / + ; +
/ +), flies expressing the wild-type Vps35 (DDC / + ; wtVPS35 / +), flies expressing
the Vps35 (D620N) mutation (DDC / + ; D620N / +), flies expressing the LRRK2
(I2020T) mutation (DDC / +; + / LRRK2), flies expressing both the Vps35 (D620N)
mutation and the LRRK2 (I2020T) mutation (DDC / + ; D620N / LRRK2), and flies
expressing the wild-type Vps35 and the LRRK2 (I2020T) mutation (DDC / + ;
wtVPS35 / LRRK2) to examine the effects of only the Vps35 mutation, then only the
LRRK2 mutation, and then the interplay of the Vps35 wild-type and mutant forms
with the mutant LRRK2 on locomotor functions in Drosophila. Climbing ability was
categorized as normal, impaired, or rescued.

Figure 4. A representation of the climbing assay experimental setup. The vial,
with 20 flies, is tapped three times to bring the flies to the bottom of the vial. As they
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begin to climb up the vial, the number of flies that cross the red line in 10s and 20s
are recorded and filmed.

b) Eye Pigmentation Analysis

An eye pigmentation analysis is used to assess the phenotypic effects of
neurodegeneration. As previously stated, the photoreceptor neurons of the
Drosophila compound eye manifest neurodegeneration through pigmentation loss,
disorganization of bristles and/or ommatidia components (also called the “rough eye”
phenotype), and the presence of black lesions.
The GMR-Gal4 system was used to drive the expression of transgenes of
interest in the Drosophila eye. The eye pigmentation analysis was assessed in wildtype flies without any mutations (GMR / + ; + / +), flies expressing the wild-type
Vps35 (GMR / + ; wtVPS35 / +), flies expressing the Vps35 (D620N) mutation
(GMR / + ; D620N / +), flies expressing the LRRK2 (I2020T) mutation (GMR / +; + /
LRRK2), flies expressing both the Vps35 (D620N) mutation and the LRRK2
(I2020T) mutation (GMR / + ; D620N / LRRK2), and flies expressing the wild-type
Vps35 and the LRRK2 (I2020T) mutation (GMR / + ; wtVPS35 / LRRK2).
Pigmentation loss was categorized as none, low, high, or rescued. A rough eye
phenotype was noted as glossy or misshapen eyes. The presence of black lesions was
also noted.
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IV.

COMPOSITE EXPERIMENTAL FINDINGS

a) Proposed mechanism of mutant Vps35 (D620N)-induced neurodegeneration

The retromer complex is necessary for proper recruitment of the WASH complex to
the endosomal membrane through the binding of Vps35 to Fam21. Evidence has
shown, however, that the expression of the Vps35 (D620N) mutation impairs
retromer association with the WASH complex, due to a large decrease in affinity of
mutated Vps35 for Fam21 of the WASH complex (McGough et al., 2014, Zavodszky
et al., 2014).
By examining the effect of the Vps35 (D620N) mutation on both the
endosome-to-TGN transport of CIMPR and the endosome-to-plasma membrane
transport of GLUT1, McGough et al. found that the mutated Vps35 impaired
endosome-to-TGN transport but did not affect the endosome-to-plasma membrane
transport (2014). Further experiments established that the Vps35 (D620N) does not
affect the formation of the cargo-recognition complex of the retromer–in that it
demonstrates an ability to bind to Vps26 and Vps29 with the same affinity and
thermodynamic properties as wild-type Vps35–nor does it inhibit the endosomal
localization of Vps35 (Fig 5) (Zavodzsky et al.,2014; Follett et al., 2016).
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Figure 5. The effect of mutant Vps35 (D620N) on association with proteins of the
CRC and WASH complex. Lanes 2 and 4 represent stably transfected and
transiently transfected fluorescently tagged wild type VPS35, respectively. Wild type
Vps35 shows normal association with the CRC proteins Vps26 and Vps29, as well as
the WASH proteins Strump (strumpellin) and Wash1. Lanes 3 and 6 represent stably
transfected and transiently transfected fluorescently tagged mutant Vps35 (D620N),
respectively. The D620N mutant shows normal association with the CRC proteins
Vps26 and Vps29 but shows decreased association with the WASH proteins
strumpellin and Wash1 (Figure courtesy of Zavodszky et al., 2014).

The impaired association of the retromer with the WASH complex, however,
disrupts autophagy through abnormal Atg9 localization and trafficking. Atg9
normally colocalizes with both Vps35 on sorting endosomes–operating through some
of the same domains at which the retromer functions–and with the WASH complex
on endosomes. Impaired WASH recruitment to the endosomal membrane, as a result
of the Vps35 D620N mutation, thereby perturbs proper trafficking of Atg9
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(Zavodszky et al., 2014). Mutant D620N cells show significantly increased abnormal
colocalization between Atg9 and TGN46, a marker for the TGN (Fig 6).

Figure 6. The Vps35 (D620N) mutation impairs proper trafficking and
localization of ATG9A. Under normal conditions, ATG9A localizes to the TGN. In
cells expressing wild-type Vps35, ATG9A showed normal colocalization with the
TGN marker TGN46. In cells expressing mutant Vps35 (D620N), ATG9A showed
significantly increased colocalization with the TGN (Figure courtesy of Zavodszky et
al., 2014).

This abnormally localization of Atg to the TGN suggests that Atg9 could be
trapped in a perinuclear compartment. Impaired trafficking of Atg disrupts proper
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autophagosome formation–a deficit similarly observed with other PD-linked
mutations (Winslow et al., 2010). In cell lines with mutant Vps35, there is a
consistently higher percentage of transfected cells with aggregates, demonstrating a
defect in autophagosome formation and autophagic clearance. The impaired
association of retromer with the WASH complex which causes abnormal autophagy
and a subsequent build-up of toxic protein aggregates and other cellular components
as a result of the Vps35 (D620N) mutation seems a plausible mechanism by which
mutant Vps35 induces neurodegeneration (Fig 7).

Figure 7. A comparative schematic of the downstream effects of wild-type Vps35
and Vps35 (D620N) mutation. On the left, wild-type Vps35 allows for correct
association of the retromer with the WASH complex, leading to proper Atg9
trafficking and normal autophagy. With normal autophagy, autophagosomes fuse
with lysosomes to degrade unwanted proteins. On the right, the Vps35 (D620N)
mutation disrupts association of the retromer with the WASH complex, leading to
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improper Atg9 trafficking and impaired autophagy. This impaired autophagy
condition is characterized by impaired autophagosome formation causing a build-up
of protein aggregates (Figure courtesy of Wang & Bellen, 2015).
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b) LRRK2-linked neurodegeneration and association with Vps35

LRRK2 mutations recapitulate the fundamental pathological characteristics of
neurodegenerative diseases. Ectopic expression of LRRK2 causes substantial loss of
dopaminergic neurons as well as locomotor defects in Drosophila mutants.
To gain a better understanding of the physiological and pathological functions
of LRRK2 mutations, many groups study transgenic Drosophila models. Utilizing
the Drosophila UAS/Gal4 system of targeted transgene expression and selective
expression of genes allows for generation of transgenic Drosophila models
overexpressing the human LRRK2 (hLRRK2) with a specific kinase domain mutation
of isoleucine to threonine at residue 2020 (I2020T).
Through examination of four posterior paired dopaminergic clusters
(dorsolateral posterior protocerebral (PPL1), lateral posterior porotocerebral (PPL2)
and two dorsomedial posterior protocerebral clusters (PPM1/2 and PPM3),
Venderova et al. found that expression of LRRK2 mutations, under the control of the
tyrosine hydroxylase (TH) gene promotor, causes a loss of dopaminergic neurons (Fig
7) (2009).
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Figure 8. Schematic representation of the fly brain, highlighting the four posterior
paired dopaminergic clusters: PPL1, PPL2, PPM1/2, and PPM3 (Figure courtesy of
Venderova et al., 2009).

While the dopaminergic clusters of control fly brains did not show any
significant changes in number of morphology of neurons during aging, analysis of
mutant fly brains revealed loss of dopaminergic neurons most noticeably in the
PPM1/2 cluster and the PPL1 cluster, with the most prominent loss of neurons seen in
flies expressing the LRRK2 (I2020T) mutation (Fig 9).
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Figure 9. Mutant LRRK2 expression induces dopaminergic neuron death. The
number of TH positive dopaminergic neurons was significantly lower after 10 days in
the two dorsomedial posterior protocerebral clusters (PPM1/2) and the dorsolateral
posterior protocerebral cluster (PPL1) of transgenic flies expressing the LRRK2
12020T mutation (Figure courtesy of Venderova et al., 2009).

LRRK2 mutations were also found to impair Drosophila locomotor activity.
Using the climbing assay technique, locomotor defects were quantified through the
number of flies that crossed the horizontal line on the vial within a certain amount of
time. While the effects of the mutant LRRK2 were complex as a result of the age of
the fly, climbing ability in all mutant lines was impaired, with the greatest locomotor
deficit seen in LRRK2 (I2020T) mutants (Fig 10) (Venderova et al., 2009).
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Figure 10. Mutant LRRK2 expression causes locomotor defects. A climbing assay
was used to analyze the effects of the LRRK2 mutations on locomotor activity. Flies
with the mutant LRRK2 I2020T exhibited the greatest locomotor deficit, quantified
through the number of flies that crossed the horizontal line in 10 seconds in a
climbing assay (Figure courtesy of Venderova et al., 2009).

While younger transgenic flies were able to climb as well as non-mutant
control flies, their performance deteriorated at a much faster rate than the control flies
(Liu et al., 2008).
LRRK2 mutations were further shown to cause retinal degeneration, as loss of
pigmentation, disorganization of the eye structure, and black lesions in Drosophila
eyes phenotypically manifested the neurodegenerative effects of the mutations.
Ectopic expression of the LRRK2 (I2020T) mutation in the fly eye caused loss of
pigmentation and, in some cases led to the development of black lesions. Further,
sectional examination of the ommatidial structure demonstrated disruption of the
well-structured photoreceptor arrangement in flies expressing the LRRK2 (I2020T)
mutation. With glossy and rough eye surfaces in addition to disorganization of the
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bristles surrounding each photoreceptor neuron, flies with the LRRK2 (I2020T)
mutation ultimately displayed sever neurodegenerative effects (Fig 11) (Venderova et
al., 2009).

Figure 11. Mutant LRRK2 expression causes pigmentation loss and structural
abnormalities in the Drosophila eye. Wild-type Drosophila eyes exhibit a red
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pigmentation and display a highly organized structure of mechanosensory
interommatidial bristles. Transgenic Drosophila eyes exhibit pigmentation loss as
well as a disorganization of bristles (Figure courtesy of Venderova et al., 2009).

Specifically, with experimental evidence to suggest that association of wildVps35 is two-fold in their involvement with the retromer and endosomal trafficking
and sorting as well as their causal links to PD pathology, a focus on the interactions
of Vps35 and LRRK2 and the downstream effect could elucidate the molecular
mechanisms of neurodegenerative disease pathogenesis.
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c) Wild-type Vps35 rescues neurodegenerative effects of PD-linked LRRK2 mutation

Recent evidence has shown that expression of wild-type Vps35 rescues the PDassociated characteristics of flies expressing mutant LRRK2, demonstrating that
Vps35 and LRRK2 operate within common cellular pathways and genetically interact
to produce pathological features of PD.
As previously shown, the expression of the LRRK2 (I2020T) mutation causes
neurodegeneration of photoreceptor neurons in the Drosophila eye, manifest through
pigmentation loss, structural defects, and the appearance of black lesions. However,
overexpression of Vps35 completely rescued the eye phenotype of LRRK2 mutant
flies. When Vps35 was expressed, none of the flies with the mutant LRRK2
exhibited black lesions. Expressing Vps35 also ameliorated some of the pigmentation
loss seen in flies with the LRRK2 (12020T) mutation, as there was less yellow
coloration compared to flies only expressing the LRRK2 mutation (Fig 12) (Linhart et
al., 2014).
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Figure 12. Eye-specific overexpression of wild-type Vps35 rescues the black
lesion phenotype caused by the LRRK2 (I2020T) mutation. The use of the GMR
promoter allowed for targeted expression of transgenes in the eye. The Drosophila
eye displays black lesions when only the mutant LRRK2 is expressed. When wildtype Vps35 is expressed with the mutant LRRK2, there are no black lesions (Figure
courtesy of Linhart et al., 2014).

Expression of the LRRK2 (I2020T) mutation also causes locomotor defects.
Transgenic flies with the LRRK2 mutation expressed in dopaminergic neurons had
significant locomotor defects–manifest through their impaired climbing ability.
However, overexpression of Vps35 rescued the locomotor defects caused by the
LRRK2 (I2020T) mutation, as a larger percent of flies expressing wild-type Vps35
and mutant LRRK2 were able to cross the line in 5 seconds as compared to transgenic
flies not expressing the wild-type Vps35 (Fig 13) (Linhart et al., 2014).

Figure 13. Overexpression of wild-type Vps35 rescues the locomotor defects
caused by mutant LRRK2 I2020T. The use of the DDC driver allowed for targeted
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expression of the transgenes in dopaminergic neurons. Flies expressing the LRRK2
mutation had a statistically significant lower percentage of flies cross the line in 5
seconds compared to wild-type control flies in a climbing assay. Flies expressing the
wild-type Vps35 and LRRK2 mutation had a statistically significant increase in
percentage of flies that crossed the line in 5 seconds compared to flies only
expression the LRRK2 mutation (Figure courtesy of Linhart et al., 2014).
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V.

IMPLICATIONS AND FUTURE DIRECTIONS

While the molecular mechanisms and cellular pathways underlying Parkinson’s
disease pathology are still not fully understood, evidence of a functional interaction
between Vps35 and LRRK2 provides immense insight into the ways PD-linked genes
may interplay within a common pathway and also strongly implicates the retromer
complex in the progression of neurodegenerative diseases, especially PD.
Continued research in the field of Parkinson’s disease is crucial given the
disparity between effective treatments for neurodegenerative disorders and the
increasing prevalence of these diseases as a greater percentage of the population ages.
Emerging evidence pointing to the integral role of the retromer in PD pathology has
allowed for a greater focus on its cellular pathways and molecular mechanisms.
While the specific Vps35 (D620N) mutation has been implicated in PD pathology as
a result of its disruption of WASH and retromer association and impairment of proper
autophagy, both the retromer and WASH complexes have many other components
that also play important roles in endosomal sorting and recycling.
Preliminary data has shown links between PD-like pathology and mutations in
various components of the retromer and WASH complexes, including the receptormediated endocytosis-8 (RME-8), the family with sequence similarity 21 (FAM21),
and the WAS protein family homolog 1 (WASH1). Broader research into the role
these genes play in the retromer and WASH complexes in addition to more focused
research into the ways their variants associate with PD progression could allow for a
better insight into the molecular mechanisms of PD pathogenesis.
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Further research into the functional relationship between Vps35 and LRRK2
could also promise exciting findings. A more robust understanding of the ways in
which overexpression of wild-type Vps35 ameliorates PD pathologies, as well as
research into the plausible ability of other genes to rescue detrimental symptoms,
could point toward certain genes as potential targets for therapeutic treatments of PD.
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